FY2025 · period end Dec '25 · from the 10-K filed Apr 15, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0.07B | $0.05B | $0.05B | $0.05B | $0.06B |
| Gross Profit | $0.01B | $0.00B | $0.00B | $0.01B | $0.01B |
| Operating Income | negative: -$0.02B | negative: -$0.02B | negative: -$0.02B | negative: -$0.01B | negative: -$0.00B |
| Net Income | negative: -$0.02B | negative: -$0.02B | negative: -$0.02B | negative: -$0.01B | negative: -$0.01B |
| EPS (Diluted) | negative: -$0.63 | negative: -$1.17 | negative: -$2.15 | negative: -$33.16 | negative: -$23.74 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.07B | $0.05B | $0.07B | $0.07B | $0.05B |
| Total Liabilities | $0.05B | $0.03B | $0.03B | $0.03B | $0.05B |
| Stockholders' Equity | $0.02B | $0.02B | $0.04B | $0.04B | $0.00B |
| Cash & Equivalents | $0.00B | $0.00B | — | $0.02B | $0.00B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | negative: -$0.01B | negative: -$0.01B | negative: -$0.02B | negative: -$0.01B | negative: -$0.01B |
| Capital Expenditures | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Free Cash Flow | negative: -$0.01B | negative: -$0.01B | negative: -$0.02B | negative: -$0.01B | negative: -$0.01B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 12.1% | 7.9% | 8.1% | 11.8% | 14.8% |
| Operating Margin | negative: -25.6% | negative: -28.6% | negative: -40.9% | negative: -14.8% | negative: -8.1% |
| Net Margin | negative: -29.3% | negative: -29.7% | negative: -34.7% | negative: -27.5% | negative: -14.2% |
| Return on Equity | negative: -103.9% | negative: -66.0% | negative: -51.4% | negative: -35.2% | negative: -181.8% |
| Return on Assets | negative: -29.2% | negative: -29.8% | negative: -28.1% | negative: -20.3% | negative: -16.1% |
| Debt / Equity | — | — | — | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001477932-26-004357 | Jul 15, 2026 | Jul 16, 2026 | Jul 16, 2026 20:35 UTC | EDGAR |
| 8-K | 0001477932-26-004192 | Jun 30, 2026 | Jul 6, 2026 | Jul 6, 2026 13:30 UTC | EDGAR |
| 8-K | 0001477932-26-003403 | May 21, 2026 | May 22, 2026 | May 22, 2026 13:30 UTC | EDGAR |
| 10-Q | 0001477932-26-003357 | Mar 31, 2026 | May 20, 2026 | May 20, 2026 20:31 UTC | EDGAR |
| 8-K | 0001477932-26-002316 | Apr 15, 2026 | Apr 16, 2026 | Apr 16, 2026 15:15 UTC | EDGAR |
| 10-K | 0001477932-26-002278 | Dec 31, 2025 | Apr 15, 2026 | Apr 15, 2026 20:34 UTC | EDGAR |
| 8-K | 0001477932-25-009040 | Dec 11, 2025 | Dec 18, 2025 | Dec 18, 2025 15:23 UTC | EDGAR |
| 8-K | 0001477932-25-008402 | Nov 17, 2025 | Nov 17, 2025 | Nov 17, 2025 21:30 UTC | EDGAR |
Direct links to SEC EDGAR. COSM has additional filings available on the SEC site.
6 numbers Cosmos Health Inc. later changed — same XBRL tag, both filings linked.
Net Income (Loss) Attributable to Parent·Q3 2024
Major restatementwas-$2.2M
Revised down in a 10-Q.
Stockholders' Equity Attributable to Parent·As of Mar 31, 2022
Notable restatementwas$5.2M
Revised down in a 10-Q.
Net Cash Provided by (Used in) Investing Activities·Q3 2016
Major restatementwas-$152.4K
Revised up in a 10-Q.
Net Cash Provided by (Used in) Financing Activities·Q3 2016
Notable restatementwas$1.8M
Revised down in a 10-Q.
Assets, Current·As of Dec 31, 2021
Notable restatementwas$40.9M
Revised down in a 10-K.
Liabilities, Current·As of Dec 31, 2020
Minor restatementwas$34.8M
Revised down in a 10-K/A.
COSM is not the only one.
See every restatement we've found across the market — or get an alert the next time COSM revises a number.
Restatements are detected by comparing every vintage of a fact across all of Cosmos Health Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows COSM's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Cosmos Health Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on COSM yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on COSM and publish the result to your public profile.
Ask about Cosmos Health Inc.
Continue in Workspace — cited answers on COSM, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs